Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Io Therapeutics Inc.
DescriptionPan-retinoic acid receptor (RAR) antagonist
Molecular Target Retinoic acid receptor (RAR)
Mechanism of ActionRetinoic acid receptor (RAR) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationNeutropenia
Indication DetailsPrevent chemotherapy-induced neutropenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today